Skip to Main Content

INFORMATION FOR

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

Conditions

Mental Health & Behavioral Research

Phase Pilot

What is the purpose of this trial?

The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.

  • Trial with
    Yale University School of Medicine
  • Start Date
    07/27/2018
  • End Date
    07/31/2024

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #2000023688